CLIA Laboratory Citation Details
42D1047824
Survey Type: Standard
Survey Event ID: EDEP11
Deficiency Tags: D0000 D5209 D6031 D6045 D6046 D6053 D5217 D5291 D5407 D6054
Summary Statement of Deficiencies D0000 An onsite announced recertification survey was conducted at Charleston Center on May 18, 2026, by the South Carolina Department of Public Health (SC DPH), Bureau of Nursing Homes and Medical Services. The facility was found to be out of compliance with the Medicare Conditions 42 CFR Part 493, CLIA laboratory requirements. The following STANDARD LEVEL DEFICINCIES were found to be out of compliance as a result of the recertification survey on May 18, 2026: D5209 PERSONNEL COMPETENCY ASSESSMENT POLICIES CFR(s): 493.1235 As specified in the personnel requirements in subpart M, the laboratory must establish and follow written policies and procedures to assess employee and, if applicable, consultant competency. This STANDARD is not met as evidenced by: Based on record review, lack of documentation, and staff interview, the laboratory failed to establish and/or follow written policies to assess employees for 3 out of 3 years reviewed (20023, 2024, and 2025). Findings included: 1. Review of CMS 209 Personnel Report record reveals 2 testing personnel. a. TP1 b. TP2 2. The surveyor requested and the laboratory failed to provide a written policy on personnel competency assessment. 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 5 -- This STANDARD is not met as evidenced by: Based on record review and staff interview, the laboratory failed to verify the accuracy of the tests twice annually as required 493.1236 for 3 out of 3 years reviewed (2023, 2024, and 2025). Findings included: 1. A review of American Proficiency Institute (API) records reveals the following results: a. 2023 Chemistry- Miscellaneous-1st Event, Urine Drug Screen (UDS) Amphetamines qualitative (qual), received unsatisfactory score of 33%. a. 2023 Chemistry-Miscellaneous-1st Event, Urine Drug Screen (UDS) Amphetamines qualitative (qual), received unsatisfactory score of 33% b. 2023 Chemistry- Miscellaneous-1st Event, UDS Buprenorphine (qual), received unsatisfactory score of 33%. c. 2023 Chemistry- Miscellaneous-2nd Event, UDS Ethyl Glucuronide, received unsatisfactory score of 0%. d. 2023 Chemistry- Miscellaneous-2nd Event, UDS Amphetamines (qual), received unsatisfactory score of 0%. e. 2023 Chemistry- Miscellaneous-2nd Event, UDS Benzodiazepines (qual), received unsatisfactory score of 0%. f. 2023 Chemistry- Miscellaneous-2nd Event, UDS Cannabinoids (qual), received unsatisfactory score of 0%. g. 2023 Chemistry- Miscellaneous-2nd Event, UDS Cocaine Metabolites (qual), received unsatisfactory score of 0%. h. 2023 Chemistry- Miscellaneous-2nd Event, UDS Methadone (qual), received unsatisfactory score of 0%. i. 2023 Chemistry- Miscellaneous-2nd Event, UDS Opiates (qual) , received unsatisfactory score of 0%. j. 2023 Chemistry- Miscellaneous-2nd Event, UDS Oxycodone (qual), received unsatisfactory score of 0%. k. 2024 Chemistry- Miscellaneous-1st Event, UDS Cocaine Metabolites (qual), received unsatisfactory score of 67%. l. 2024 Chemistry- Miscellaneous-2nd Event, Ethyl Glucuronide, received unsatisfactory score of 67%. m. 2025 Chemistry- Miscellaneous-2nd Event, Ethyl Glucuronide, received unsatisfactory score of 67%. 2. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D5291 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess, and, when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. This STANDARD is not met as evidenced by: Based on policies and procedures review, lack of documentation, and staff interview, the laboratory failed to follow written policies and procedures for an ongoing mechanism to monitor, assess, and when indicated, correct problems identified in the general laboratory systems requirements specified at 493.1231 through 493.1236. Findings included: 1. Review of policy titled "UDS Quality Assurance Program" reveals the laboratory Quality Assurance Program would identify, correct, and communicate problems to assure the accurate, reporting of test results. The results of all QA findings will be discussed with the laboratory staff, and a copy of the QA program findings will be kept in the Quality Assurance Binder. 2. The surveyor requested and the laboratory failed to provide documentation of QA findings with laboratory director and staff for 3 out of 3 years reviewed (2023, 2024, and 2025). 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D5407 PROCEDURE MANUAL -- 2 of 5 -- CFR(s): 493.1251(d) (d) Procedures and changes in procedures must be approved, signed, and dated by the current laboratory director before use. This STANDARD is not met as evidenced by: Based on policies and procedures reviewed, lack of documentation, and staff interview, the laboratory director failed to approve procedure changes by signing and dating the change for the 3 out of 3 years reviewed (2023, 2024, and 2025). Findings included: 1. A review of "UDS Quality Assurance Program" policy reveals Effective Date 12-05, Policy Number 6.1, Page Number 2 of 2, a change was made. The test menu was updated to add Barbiturates (BARBS) and Ecstasy (MDMA). 2. The policy lacked documentation about when the procedure was updated/approved and what date it was communicated to staff. 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D6031 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(13) (e)(13) Ensure that an approved procedure manual is available to all personnel responsible for any aspect of the testing process; and This STANDARD is not met as evidenced by: Based on record review, lack of documentation, and staff interview, the laboratory director failed to ensure that an approved procedure manual is available to all personnel responsible for any aspect of the testing process for 3 of 3 years reviewed (2024, 2025, and 2026). Findings included: 1. Review of policies and procedures reveals the laboratory lack written procedure for tests performed on the new Beckman AU 480 analyzer installed April 2025. 2. Review of policies and procedures reveals the laboratory lack documentation of director's approval for the Beckman AU 480 analyzer installed April 2025. 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D6045 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(7) (b)(7) Identifying training needs and assuring that each individual performing tests receives regular in-service training and education appropriate for the type and complexity of the laboratory services performed; This STANDARD is not met as evidenced by: Based on record review, lack of documentation, and staff interview, the Technical Consultant failed to document the training and education provided to testing personnel (TP) for moderately complex testing performed for the 3 out of 3 years reviewed (2024, 2025, and 2026). Findings included: 1. Records reviewed (CMS 209 Personnel Report form and API Attestation Statements) reveal 2 TPs. a. TP1 b. TP2 c. TP2, 2024 Chemistry-Miscellaneous-2nd Event signed attestation statement October 25, 2024 2. The surveyor requested and the laboratory failed to provide training records -- 3 of 5 -- for 1 out of 2 TP hired in 2024. a. TP2 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D6046 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(8) (b)(8) Evaluating the competency of all testing personnel and assuring that the staff maintain their competency to perform test procedures and report test results promptly, accurately and proficiently. The procedures for evaluation of the competency of the staff must include, but are not limited to-- This STANDARD is not met as evidenced by: Based on record review, lack of documentation, and staff interview, the Technical Consultant failed to document and include all 6 competency assessment procedures for 2 out of 2 TP performing patient testing as required 493.1413(b)(8) for 3 out of 3 years reviewed (2024, 2025, and 2026). Findings included: 1. Review of CMS 209 Personnel Report Form and PT attestation sheets reveal 2 TP. a. TP1 b. TP2 2. The surveyor requested competency evaluations for both TPs and the laboratory lack documentation for 3 out of 3 years for 2 out of 2 TPs performing moderately complex testing. 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D6053 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(9) (b)(9) Evaluating and documenting the performance of individuals responsible for moderate complexity testing at least semiannually during the first year the individual tests patient specimens. This STANDARD is not met as evidenced by: Based on record review, lack of documentation, and staff interview, the TC/laboratory director failed to evaluate and/or document the performance of individuals responsible for moderate complexity testing at least semiannually during the first year the individual tested patient specimens for 1 out of 2 testing personnel (TP). Findings included: 1. Review of CMS 209 Personnel Report Form and PT attestation records reveal 2 TP. a. TP1 b. 2TP2 c. TP2, 2024 Chemistry-Misellaneous-2nd Event signed attestation statement October 25, 2024 d. TP2, 2025 Chemistry-Misellaneous-1st Event signed attestation statement May 7, 2025. 2. The surveyor requested and the laboratory failed to provide semiannually competency for TP2 hired 2024. 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. D6054 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(9) (b)(9) Thereafter, evaluations must be performed at least annually This STANDARD is not met as evidenced by: Based on record review, lack of documentation, and staff interview, the TC/laboratory -- 4 of 5 -- director failed to evaluate and/or document the performance of individuals responsible for moderate complexity testing at least annually for individuals testing patient specimens for 2 out of 2 testing personnel (TP). Findings included: 1. Review of CMS 209 Personnel Report record reveals 2 testing personnel. a. TP1 b. TP2 2. The surveyor requested and the laboratory failed to provide annual competency for 2 out of 2 TP. 3. In an interview on May 18, 2026, at 4:52 pm in the conference room with office manager and TP1 the above findings were confirmed. -- 5 of 5 --
Get full access to the detailed deficiency summary for this facility
Survey Type: Standard
Survey Event ID: 9C8C11
Deficiency Tags: D2009 D0000 D6046
Summary Statement of Deficiencies D0000 A Recertification Survey was initiated on 09/22/2023 and concluded on 09/22/2023. The facility was found not to be in compliance with the laboratory requirements of 42 CFR Part 493 with deficiencies cited. D2009 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The individual testing or examining the samples and the laboratory director must attest to the routine integration of the samples into the patient workload using the laboratory's routine methods. This STANDARD is not met as evidenced by: Based on document review and interview, the laboratory failed to ensure a laboratory director and testing personnel signed a proficiency testing attestation statement for 1 of 3 proficiency test events reviewed. Findings included: A review of a "2023 Chemistry Miscellaneous 1st Event Attestation Statement" indicated, "An attestation statement must be signed by testing personnel and the laboratory director and retained for a minimum of 2 years." The review revealed that the statement was not signed by the laboratory director or the person(s) who performed the test. During an interview on 09/22/2023 at 11:40 AM, Testing Personnel (TP) #2 stated that they usually did not complete the attestation forms for proficiency testing. The attestation statement forms for 2022, events 1 and 2, were not available for review. D6046 TECHNICAL CONSULTANT RESPONSIBILITIES CFR(s): 493.1413(b)(8) (b) The technical consultant is responsible for-- (b)(8) Evaluating the competency of all testing personnel and assuring that the staff maintain their competency to perform test procedures and report test results promptly, accurately and proficiently. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on observation, interviews, and document review, the laboratory failed to ensure that an initial competency assessment was documented for 1 (Testing Personnel [TP] #1) of 2 testing personnel reviewed. Findings included: During the laboratory tour on 09/22/2023 at 10:00 AM, TP #1 was observed loading samples on a urine drug screen analyzer. During an interview at 10:00 AM, TP #1 provided an overview of specimen collection, preparation, and testing on the analyzer. A review of TP #1's personnel file revealed TP #1 started working in the laboratory on 10/07 /2022. In response to a request for evidence showing TP #1 received initial training on using the analyzer, the facility provided TP #1's completion certificates from the manufacturer's online modules. During an interview on 09/22/2023 at 11:05 AM, TP #2 stated they observed TP #1 perform laboratory testing and tasks after completion of each online module, but the performance was not documented. -- 2 of 2 --
Get full access to the detailed deficiency summary for this facility